Prostate-specific membrane antigen positron emission tomography in the management of recurrent prostate cancer

There is an unmet clinical need for early, accurate imaging of recurrent prostate cancer to improve patient outcomes. Staging, by conventional bone scintigraphy and CT have become outdated. 68Ga-PSMA PET/CT imaging in this setting has developed rapidly, with widespread International adoption in line with evidence-based guidelines in this group of patients. A PubMed search of English language articles was performed using following keywords: PSMA,...